Panelists discuss how myelofibrosis progresses from its molecular and genetic origins through various clinical manifestations ...

Source: Getty Images Primary myelofibrosis is a rare cancer. In the United States (US), the annual incidence is approximately 0.3 cases per 100,000 individuals. The median age of patients with ...

Ten days of subcutaneous Dacogen resulted in responses among a third of patients with myelofibrosis. Among patients with ...

For the last few decades, JAK inhibitors have been the mainstay treatment for patients who have been diagnosed with myelofibrosis. The treatment landscape of myelofibrosis has undergone a significant ...

Panelists discuss how health care providers can optimize quality-of-life and treatment outcomes for patients with myelofibrosis through comprehensive symptom management, shared decision-making, and ...

A bone marrow biopsy can identify diseases of the bone marrow, including myelodysplastic syndrome or myelofibrosis, and conditions that affect the blood cells, such as leukopenia, polycythemia ...

Below is a list of the possible therapeutic options: Chemotherapy these include medications that reduce platelet and alter bone marrow's ability to make and produce blood cells (ex. hydroxyurea ...

The bone marrow is the spongy part of your bones where oxygen-carrying red bloods, infection-fighting white blood cells, and clot-forming platelets are made. The bone marrow is a soft tissue with many ...